IRCT20210713051878N1 IRCT 2022-09-08 Islamic Azad University Atorvastatin effect on ulcerative colitis Evaluation of atorvastatin effect on disease severity and quality of life in ulcerative colitis patients. 2021-08-22 anticipated 40 Complete https://irct.ir/trial/57533 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is based on block randomization in blocks of four, This list is built up by an online software available at www.random.org website. Patients were divided in two groups of twenty patients based on blocks of four. One group of twenty patients will receive treatment and the other group will receive placebo. The researcher is not aware about patients allocation, Blinding description: Drug and placebo are filled by a third person in same packs and coding's are included by two numbers and two letters ( unique codes assigned for each packs). Researcher is blinded about these codes up to end of the search. 2 Ulcerative colitis. Intervention 1: Intervention group: 20 patients of ulcerative colitis who refer to gastrointestinal department of Bouali hopital (Tehran-Iran) will receive atorvastatin 40mg (Sobhan Darou-Rasht-Iran) in similar packs and will take them once daily oral used for 2 months. Intervention 2: Control group: 20 patients of ulcerative colitis who refer to gastrointestinal department of Bouali hopital (Tehran-Iran) will receive placebo tablets that made in Tehran medical science Islamic Azad University in similar packs and will take them once daily oral used for 2 months. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information.